New device competent authority for Estonia
This article was originally published in RAJ Devices
Responsibility for medical device supervision in Estonia will transfer from the State Agency of Medicines to the newly formed Health Board on 1 January1.
You may also be interested in...
EU approval is a formality for the eight products given the nod this week at the European Medicines Agency. There's no word, though, on filgotimid, from Gilead/Galapagos.
The May meeting of the European Medicines Agency’s drug evaluation committee, the CHMP, is under way. Decisions are due on whether eight marketing approval applications should be approved for marketing in the EU.
Alnylam and Eiger join the select group of companies whose products have been granted fast-track status at the European Medicines Agency